Header Logo

Connection

Taha Alrifai to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Taha Alrifai has written about Treatment Outcome.
Taha Alrifai
Connection Strength
0.074
Treatment Outcome
  1. Bendamustine and Rituximab: Complete Response in a 62-Year-Old Female with an Aggressive Lymphoma and an Ejection Fraction of 20. Chemotherapy. 2017; 62(2):140-146.
    View in: PubMed
    Score: 0.074
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.